Discover
VKTX
Viking Therapeutics, Inc.
37.48
1 x 35.20
1 x 38.90
bid
ask
-
1.53
3.92%
1 @ 04:00 PM
37.80 +0.32 (0.85%)
| Ytd | 6.54% | |
| 1y | 40.53% |
36.96
day range
39.66
22.96
52 week range
43.15
| Open | 38.95 | Prev Close | 39.01 | Low | 36.96 | High | 39.66 | Mkt Cap | 4.35B |
| Vol | 3.10M | Avg Vol | 2.39M | EPS | -4.15 | P/E | N/A | Forward P/E | -8.54 |
| Beta | 0.68 | Short Ratio | 11.81 | Inst. Own | 64.53% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-29 | 50-d Avg | 31.79 | 200-d Avg | 32.86 | 1yr Est | 92.58 |
| Income Statement | |||
| Operating Expenses | 164.13M | ||
| Research and Development Expense | 150.15M | ||
| Selling, General and Administrative Expense | 13.98M | ||
| Operating Income | -164.12M | ||
| Net Income | -158.32M | ||
| Net Income Common Stock | -158.32M | ||
| Net Income Common Stock (USD) | -158.32M | ||
| Consolidated Income | -158.32M | ||
| Earnings per Basic Share | -1.37 | ||
| Earnings per Basic Share (USD) | -1.37 | ||
| Earnings per Diluted Share | -1.37 | ||
| Earning Before Interest & Taxes (EBIT) | -158.32M | ||
| Earning Before Interest & Taxes (USD) | -158.32M | ||
| Weighted Average Shares | 115.57M | ||
| Weighted Average Shares Diluted | 115.57M | ||
| Balance Sheet | |||
| Cash and Equivalents | 118.15M | ||
| Cash and Equivalents (USD) | 118.15M | ||
| Investments | 484.85M | ||
| Investments Current | 484.85M | ||
| Current Assets | 608.21M | ||
| Total Assets | 608.24M | ||
| Current Liabilities | 106.33M | ||
| Total Liabilities | 106.33M | ||
| Accumulated Retained Earnings (Deficit) | -1.01B | ||
| Accumulated Other Comprehensive Income | -856.00K | ||
| Shareholders Equity | 501.92M | ||
| Shareholders Equity (USD) | 501.92M | ||
| Assets Non-Current | 33.00K | ||
| Trade and Non-Trade Payables | 67.18M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 85.00K | ||
| Net Cash Flow from Financing | 12.08M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -47.71M | ||
| Issuance (Purchase) of Equity Shares | 12.08M | ||
| Net Cash Flow from Investing | 54.19M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 54.19M | ||
| Net Cash Flow from Operations | -113.98M | ||
| Effect of Exchange Rate Changes on Cash | 16.00K | ||
| Share Based Compensation | 10.34M | ||